Université Paris DescartesFriday 6th October 2017
8h30—9h00
Welcome coffee
9h00—9h10
Introduction
2017-10-06 09:00:00
Welcome coffee
Introduction
Session 1: Pediatric Tumors (Chairs: Olivier Delattre/Jessica Zucman-Rossi)
Olivier Delattre, Institut Curie, Paris, France
“Cell identidy and plasticity in childhood cancers”
Stefan Pfister, German Cancer Research Center (DKFZ), Heidelberg, Germany
“Next generation pediatric neurooncology”
Stephen Chanock, National Cancer Institute , Rockville,Maryland, USA
“The complexity of Genetic Susceptibility to Cancer”
Amaury Leruste, Institut Curie, Paris, France
“Analysis of immune infiltrate identifies checkpoint blockade and TLR3 activation as efficient synergistic combination of immunotherapy in rhabdoid tumors”
Coffee break
Session 2: Genomics and therapies (Chairs: Pierre Laurent-Puig/Fabien Calvo)
Nuria Lopez-Bigas, Institute for Research in Biomedecine IRB, Barcelona, Spain
“Coding and non-coding mutations in cancer genomes”
Lodewyk Wessels, Netherlands Cancer Institute, Amsterdam, Netherland
“Response and outcome prediction based on molecular networks”
Roxanne Pommier, Centre de Recherche en Cancérologie de Lyon, Lyon, France
“Multi-omics characterization of claudin-low breast tumors”
Camilla Pilati, Inserm Université Paris Descartes UMR1147, Paris, France
“Exome sequencing identifies ERBB3 and MEK1 mutations as associated with resistance to anti-EGFR antibodies in colorectal cancer“
Lunch
Session 3: Genomic signatures and exposure (Chairs: Eric Letouzé/Rebecca Fitzgerald)
Laurence Zitvogel, Institut Gustave Roussy IGR, Villejuif, France
“Beneficial Microbes in colon cancer”
Rebecca Fitzgerald, MRC Cancer Unit, Cambridge, UK
“Unravelling the genomic landscape of cancer of the oesophagus and applications to earlier diagnosis”
Jessica Zucman-Rossi, Inserm Université Paris Descartes UMR1162, Paris, France
“Viral infection and liver cancer”
Eric Letouzé, Inserm Université Paris Descartes UMR1162, Paris, France
“Dynamic interplay of risk factors, cellular processes and driver genes in liver tumors”
Coffee break
Session 4: Perspectives in cancer genomics (Chairs: Alain Puisieux/Laurence Zitvogel)
Brooke Laflamme, Chief Editor, Communications Biology, New York, USA
“An editorial perspective on the future of cancer genomics”
Mike Stratton, Wellcome Trust Sanger Institute, Cambridge, UK
“Signatures of mutational processes in human cancer“
Conclusion and Gilles Thomas Award for young researcher
